TrialBritish journal of cancer2009

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.

D A Reardon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.